Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 16.80
  • 0.16  -0.94%
    Today's Change
  • 16.96
    Previous Close
  • Today
    52 Week Low - High
2:10 pm ET 7/2/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding48 million
Market Cap$802 million
Return on Equity ttm58.79%
Last DividendSUPN:US does not pay a dividend
EPS: Year Actual ttm0.858
EPS: Year Est. 12/15 ttm0.155
EPS: Quarterly Actual 3/15 0.05
EPS: Quarterly Est. 6/15 0.02
Price/Earnings ttm19.58
Relative Price/Earnings--
Earnings Growth Rate--
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$122 million
Net Income$20 million
Total Assets$138 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!